Literature DB >> 33175296

In systemic sclerosis patients the anxiety disorder and Raynaud's phenomenon are increased during lock down period for COVID-19 pandemic.

Antonietta Gigante1, Annalisa Villa1, Chiara Pellicano1, Edoardo Rosato2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33175296      PMCID: PMC7656092          DOI: 10.1007/s11739-020-02557-z

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
Dear Editor, The outbreak of coronavirus disease (COVID-19) has radically changed the quality of life of patients with connective tissue diseases. Since systemic sclerosis (SSc) patients are susceptible to distress and psychological complications with high level of pain and disability, COVID-19 pandemic can change the course of the disease. Aim of this study was to identify factors impacting the health-related-quality of life during total Italian lockdown for COVID-19 pandemic in the Lazio region. Sixty-nine consecutive SSc patients [F = 63, median age 55 (53–63) years; 28 patients with diffuse cutaneous SSc] were enrolled in this study. The availability of questionnaires previously self-compiled between September 2019 and January 2020 is the main inclusion criteria. During COVID-19 total lockdown, the questionnaires were re-administered by telephone interview in all SSc patients. All SSc patients continued previous therapy. Health Assessment Questionnaire (HAQ) with the addition of five validated Visual Analogue Scale (VAS) instruments (pain, gastrointestinal, lung, Raynaud’s phenomenon and digital ulcers) [1], University of California, Los Angeles Scleroderma Clinical Trial Consortium Scleroderma Gastrointestinal Tract Involvement 2.0 (UCLA) [2], Generalized Anxiety Disorder 7 (GAD-7) [3] and Patient Health Questionnaire 9 (PHQ-9) [4] were analyzed pre and post total lockdown. All results are expressed as median and interquartile range. A software (SPSS version 25.0) was used for the statistical analysis. Group comparisons were made by Mann–Whitney test. Spearman’s rank coefficient was used to evaluate correlation between numerical variables. p values < 0.05 were considered significant. During the total Italian lockdown period, SSc patients showed higher score of the GAD-7 anxiety scale [6 (5–9) vs 5 (4–7), p = 0.031] and VAS of Raynaud’s phenomenon [30 (20–50) vs 20 (10–30), p = 0.014]. Gastroesophageal reflux symptoms were more prevalent in non-employed SSc patients than SSc patients employed. A positive linear correlation between delta of GAD-7 anxiety scale and delta of VAS of Raynaud’s phenomenon (r = 0.317, p = 0.008)) and between delta of GAD-7 anxiety scale and delta of HAQ (r = 0.323, p = 0.007) was found (Fig. 1a, b).
Fig. 1

a Correlation between delta of Generalized Anxiety Disorder 7 (GAD-7) and delta of Visual Analogue Scale (VAS) of Raynaud’s phenomenon. b Correlation between delta of Generalized Anxiety Disorder 7 (GAD-7) and delta of self-Health Assessment Questionnaire (sHAQ) score

a Correlation between delta of Generalized Anxiety Disorder 7 (GAD-7) and delta of Visual Analogue Scale (VAS) of Raynaud’s phenomenon. b Correlation between delta of Generalized Anxiety Disorder 7 (GAD-7) and delta of self-Health Assessment Questionnaire (sHAQ) score During the total lockdown, SSc patients showed high value of anxiety scale and worsening of Raynaud’s phenomenon. In SSc patients, Raynaud’s phenomenon is a common clinical manifestation leading to distressing physical symptoms, functional disability and reduced health-related quality of life. Cold exposure and emotional stress are the triggers of Raynaud’s phenomenon. In the Preliminary Advice for Patient Management, World Scleroderma Foundation (WSF) suggests that patients should limit their visits to the hospital/clinic until the pandemic fades and the government lifts strict rules [5]. Although the WSF recommends isolation, it can be an additional stress factor that worsens the disease especially in patients with severe form (e.g. male). Although Raynaud’s phenomenon to be more controlled with being forced at home avoiding cold exposure, but it is also true that the psychological impact of the stressful period might have overruled this advantage. Telemedicine is a viable approach to be considered for routine follow-up of patients with connective tissue diseases. Telemedicine can reduce the patient’s feeling of isolation and the level of stress [6]. The sedentary lifestyle and domestic routine, due to COVID-19 total lockdown, could probably have contribute to increase awareness of disability in daily activities. During COVID-19 total lockdown, patients without a job referred more symptoms related to gastroesophageal reflux than patients employed. Lifestyle influences gastroesophageal reflux and intestinal symptoms. In the extraordinary and prolonged condition of COVID-19 lockdown, stay-at-home routine modifies cooking and eating habits of patients, often bringing to excess in preparation and consumption of food. In SSc patients, anxiety and VAS of Raynaud’s phenomenon increased during total lockdown. Emotional stress is an important trigger of vasospastic symptoms and the physicians should take care of the psychological aspect in this cohort of patients.
  6 in total

1.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

2.  Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.

Authors:  Marco Matucci-Cerinic; Cosimo Bruni; Yannick Allanore; Massimo Clementi; Lorenzo Dagna; Nemanja S Damjanov; Amato de Paulis; Christopher P Denton; Oliver Distler; David Fox; Daniel E Furst; Dinesh Khanna; Thomas Krieg; Masataka Kuwana; Eun Bong Lee; Mengtao Li; Shiv Pillai; Yukai Wang; Xiaofeng Zeng; Gloria Taliani
Journal:  Ann Rheum Dis       Date:  2020-04-29       Impact factor: 19.103

3.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

4.  Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

Authors:  Dinesh Khanna; Ron D Hays; Paul Maranian; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Terri Getzug; Nihal Fathi; Amber Bechtel; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2009-09-15

5.  Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.

Authors:  Eun Hye Park; Vibeke Strand; Yoon Jeong Oh; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Res Ther       Date:  2019-02-15       Impact factor: 5.156

6.  Telemedicine in rheumatology: a reliable approach beyond the pandemic.

Authors:  Lorenzo Cavagna; Giovanni Zanframundo; Veronica Codullo; Maria Grazia Pisu; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

  6 in total
  1 in total

1.  Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis.

Authors:  Chiara Pellicano; Roberta Campagna; Alessandra Oliva; Giorgia Leodori; Marzia Miglionico; Amalia Colalillo; Ivano Mezzaroma; Claudio Maria Mastroianni; Ombretta Turriziani; Edoardo Rosato
Journal:  Clin Rheumatol       Date:  2022-05-26       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.